ELISA、蛋白免疫沉淀与线性印迹法检测肿瘤相关皮肌炎中抗TIF1-γ自身抗体的比较
研究纳入瑞典卡罗林斯卡大学医院随访的131例皮肌炎患者和82名健康对照,比较免疫沉淀、两种ELISA和线性印迹法检测抗TIF1-γ自身抗体的性能及识别肿瘤相关皮肌炎的能力。两种ELISA在抗体检测和识别抗TIF1-γ阳性肿瘤相关皮肌炎方面均具优势。
要点
- 抗TIF1-γ抗体检出率:免疫沉淀19/101(18.8%),线性印迹15/113(13.2%),自建ELISA 34/131(26%),商业ELISA 45/131(34.4%)。
- 识别肿瘤相关皮肌炎:自建ELISA敏感性58%、特异性86%;商业ELISA敏感性63%、特异性82%。
- 免疫沉淀敏感性52%、特异性92%;线性印迹敏感性40%、特异性96%。
核心结论
- 两种抗TIF1-γ ELISA在自身抗体检测和识别抗TIF1-γ阳性肿瘤相关皮肌炎两方面均具优势。
研究设计与样本
- 纳入瑞典斯德哥尔摩卡罗林斯卡大学医院随访的131例皮肌炎患者血清和82名健康对照。
- 采用免疫沉淀、两种ELISA(自建和商业)及线性印迹法检测皮肌炎诊断时血清中的抗TIF1-γ自身抗体。
- 肿瘤诊断及日期来自瑞典国家癌症登记,肿瘤相关皮肌炎定义为皮肌炎诊断后3年内发生的恶性肿瘤。
主要发现
- 抗TIF1-γ抗体检出:免疫沉淀19/101(18.8%),线性印迹15/113(13.2%),自建ELISA 34/131(26%),商业ELISA 45/131(34.4%)。
- 自建ELISA结果经免疫沉淀确认93/101(92%),κ=0.76;经商业ELISA确认110/131(84%),κ=0.63;经线性印迹确认101/113(89.3%),κ=0.67。
- 免疫沉淀结果经线性印迹确认85/92(92.4%),κ=0.73。
- 识别肿瘤相关皮肌炎:自建ELISA敏感性58%、特异性86%;商业ELISA敏感性63%、特异性82%。
- 识别肿瘤相关皮肌炎:免疫沉淀敏感性52%、特异性92%;线性印迹敏感性40%、特异性96%。
关键数值与推荐
- 肿瘤相关皮肌炎定义为皮肌炎诊断后3年内发生的恶性肿瘤。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Anti-TIF1-gamma autoantibodies can be detected with immunoprecipitation (IP), line blot (LB) and ELISA. We compared assay performance in patients with DM and the potential of these assays to detect anti-TIF1-gamma positive cancer-associated DM (CADM). METHODS: We included sera from 131 patients with DM followed at Karolinska University Hospital, Stockholm, Sweden and 82 healthy controls. Serum samples taken at DM diagnosis were tested for anti-TIF1-gamma autoantibodies with IP, two ELISAs (in-house and commercial) and LB. Cancer diagnosis and dates were obtained from the Swedish national cancer register. CADM was defined as a malignancy that developed within 3 years of DM diagnosis. RESULTS: Anti-TIF1-gamma autoantibodies were detected in 19/101 (18.8%), 15/113 (13.2%), 34/131 (26%) and 45/131 (34.4%) of the patients with IP, LB, in-house and commercial ELISA, respectively. The anti-TIF1-gamma results from the in-house ELISA were confirmed with IP in 93 of 101 (92%) cases, κ = 0.76, with a commercial ELISA in 110 of 131 (84%) cases, κ = 0.63, and with LB in 101 of 113 (89.3%) cases, κ = 0.67. Anti-TIF1-gamma results with IP were confirmed with LB in 85 of 92 (92.4%) cases, κ = 0.73. For detecting CADM, the anti-TIF1-gamma in-house ELISA had a sensitivity of 58% and specificity of 86%, the commercial ELISA had a sensitivity of 63% and specificity of 82%, IP had a sensitivity of 52% and specificity of 92%, LB had a sensitivity of 40% and specificity of 96%. CONCLUSION: The two anti-TIF1-gamma ELISA assays had advantages both for autoantibody detection and to identify anti-TIF1-gamma-positive CADM.
引用
- Selickaja S, Galindo-Feria AS, Dani L, et al. ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis. Rheumatology (Oxford). 2022. PMID: 35579337. doi:10.1093/rheumatology/keac288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。